Paper Details

  1. Home
  2. Paper Details

The effects of felodipine in angina pectoris.

Author: BarbourM P, FoxY, LawrieT D, LorimerA R, MacFarlaneP, PringleS

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Controlled Clinical TrialA clinical trial that evaluates the effectiveness of a treatment by comparing a group that receives the intervention with a group that receives a placebo or standard treatment.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Felodipine, in addition to a beta-blocker, modestly but significantly reduced the number of angina attacks and increased exercise capacity in patients with exertional angina pectoris.
Paper Details　
Original Abstract of the Article :
The clinical response to felodipine, in addition to a beta-blocker, was evaluated and compared with placebo in this double-blind cross-over study. Twenty patients with exertional angina pectoris completed the study. Felodipine reduced the number of angina attacks and the Glyceryl Trinitrate (GTN) co...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/BF02336676

データ提供：米国国立医学図書館（NLM）

Felodipine: A Beacon of Hope for Angina Pectoris

This study explores the effectiveness of felodipine, a calcium channel blocker, in treating angina pectoris, a condition characterized by chest pain caused by reduced blood flow to the heart. The researchers conducted a double-blind, cross-over study to compare the effects of felodipine to placebo in patients with angina pectoris. Think of felodipine as a refreshing spring of water in the heart of a desert, restoring the flow of blood and relieving the discomfort of angina. The study found that felodipine, in combination with a beta-blocker, effectively reduced angina attacks, improved exercise capacity, and lowered blood pressure, offering a ray of hope for individuals struggling with this debilitating condition.

Felodipine: A New Frontier in Angina Pectoris Treatment

The study highlights the potential of felodipine, a calcium channel blocker, to offer a new frontier in angina pectoris treatment. It's like discovering a new oasis in the desert of cardiovascular medicine, offering relief and hope for those suffering from this debilitating condition. The study's findings encourage further research into the use of felodipine for angina pectoris, paving the way for more effective and personalized treatment options.

Stay Hydrated and Manage Your Angina

The study underscores the importance of managing angina pectoris and staying vigilant about cardiovascular health. It's like navigating a vast desert, where staying hydrated and maintaining your physical well-being is crucial for survival. The study highlights the importance of working with healthcare professionals to manage angina effectively, ensuring a healthier and more fulfilling life.

Dr. Camel's Conclusion

This study offers a refreshing glimpse into the potential of felodipine for treating angina pectoris, a condition that can often feel like navigating a desert of discomfort. The study's findings provide a ray of hope for individuals struggling with angina, reminding us that even in the most challenging conditions, there are often solutions to be found. The research encourages further investigation into the use of felodipine, paving the way for more effective and personalized treatments.
Date :
  1. Date Completed 1990-09-12
  2. Date Revised 2019-08-13
Further Info :

Pubmed ID

2116311

DOI: Digital Object Identifier

10.1007/BF02336676

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.